Genmab A/S
$33.29
+0.13 (+0.39%)
Price as of Sep 01, 2026 market close
Performance
- 1 Month
- +16.1%
- 3 Months
- +39.6%
- YTD
- +8.1%
- 1 Year
- +33.9%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 33.8%
- Largest decline max drawdown, since Aug 2025
- -32.5%
- Risk-adjusted return Sharpe ratio, 1-year
- 1.03
Own GMAB?
See how GMAB contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.